Miltenyi Biotec acquires biosensor company lino Biotech
March 15, 2023
ZURICH -- lino Biotech, a leading biosensor company and the world's only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in [...]
March 15, 2023
GSG GENII Software Group (“GENII”) today announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory process. Based in Zwolle, The Netherlands, iVention deploys its solutions via [...]
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
March 15, 2023
Enhanced usability to support PCR applications in basic and translational research, process development, and quality control HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR [...]
March 15, 2023
SAN DIEGO -- Bionano Laboratories today announced the expansion of its clinical testing menu with the launch of two new laboratory developed tests (LDTs) based on optical genome mapping (OGM), OGM-DxTM Postnatal Whole Genome SV and OGM-DxTM Prenatal Whole Genome SV. These LDTs offer a genome-wide assessment of structural variants (SVs) and provide comprehensive testing for most [...]
March 15, 2023
An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery HOLLISTER, Calif. -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius, today announced that the companies have entered into a collaboration arrangement that will help gene [...]
March 15, 2023
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its participation in the Cell and Gene Therapy Catapult Process Analytical Technology (Catapult PAT) consortium, a multi-year collaboration involving 24 partner companies, technology providers, therapy developers, and charities. The Catapult PAT consortium is the first initiative of this scale and functional expertise with member companies [...]
Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
March 15, 2023
Experienced Life Science Operating Leader Joins Board as Company Enters New Phase SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the appointment of Fenel Eloi to its Board of Directors (“Board”). Eloi will also serve on the Board’s Audit Committee. [...]
Illumina launches its first product enabling long- and short-read sequencing on one instrument
March 14, 2023
Early customer data reinforces accuracy and flexibility of novel long-read technology, unlocking access to challenging, low DNA input samples SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order. The [...]
PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes
March 14, 2023
Paraphase Enables Researchers to Analyze Genes That are Critically Relevant but Hard to Genotype MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a new informatics method that genotypes gene paralogs and pseudogenes with high accuracy. The new computational tool, named "Paraphase," enables variant calling, copy number analysis and phasing [...]
Market Disruptor Axion BioSystems Rejects Agilent Technologies, Inc. Allegations
March 14, 2023
ATLANTA -- Axion BioSystems vigorously refutes a recent filing by Agilent Technologies, Inc. (NYSE: A) claiming patent infringement and false advertising. As a recognized biotechnology innovator and owner of numerous patents over 14 years, Axion BioSystems expects its competitors to respect its intellectual property rights, just as Axion respects the intellectual property rights of its [...]

